PRSS54
gene geneOn this page
Also known as FLJ25339KLKBL4CT67
Summary
PRSS54 (serine protease 54, HGNC:26336) is a protein-coding gene on chromosome 16q21, encoding Inactive serine protease 54 (Q6PEW0).
This gene encodes a putative serine-type endopeptidase containing the peptidase S1 domain. Alternative splicing of this gene results in multiple transcript variants.
Source: NCBI Gene 221191 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_001305173
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26336 |
| Approved symbol | PRSS54 |
| Name | serine protease 54 |
| Location | 16q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25339, KLKBL4, CT67 |
| Ensembl gene | ENSG00000103023 |
| Ensembl biotype | protein_coding |
| Entrez | 221191 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000219301, ENST00000543437, ENST00000563336, ENST00000567164, ENST00000569079, ENST00000569727
RefSeq mRNA: 3 — MANE Select: NM_001305173
NM_001080492, NM_001305173, NM_001305174
CCDS: CCDS32463, CCDS76882
Canonical transcript exons
ENST00000567164 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000686751 | 58284590 | 58284721 |
| ENSE00001298781 | 58279997 | 58280757 |
| ENSE00001504118 | 58290959 | 58291136 |
| ENSE00002579515 | 58293985 | 58294209 |
| ENSE00002620499 | 58294887 | 58295025 |
| ENSE00003498476 | 58285937 | 58286195 |
| ENSE00003542823 | 58293732 | 58293822 |
Expression profiles
Bgee: expression breadth broad, 80 present calls, max score 91.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0565 / max 54.1302, expressed in 4 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157614 | 0.0379 | 3 |
| 157615 | 0.0086 | 3 |
| 207902 | 0.0059 | 4 |
| 157613 | 0.0042 | 3 |
Top tissues by expression
223 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 91.11 | gold quality |
| sperm | CL:0000019 | 90.83 | gold quality |
| right testis | UBERON:0004534 | 90.82 | gold quality |
| testis | UBERON:0000473 | 88.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.64 | silver quality |
| adult organism | UBERON:0007023 | 72.64 | gold quality |
| buccal mucosa cell | CL:0002336 | 65.57 | gold quality |
| medial globus pallidus | UBERON:0002477 | 61.55 | silver quality |
| oviduct epithelium | UBERON:0004804 | 61.46 | silver quality |
| tibia | UBERON:0000979 | 58.70 | silver quality |
| globus pallidus | UBERON:0001875 | 57.02 | silver quality |
| cartilage tissue | UBERON:0002418 | 55.66 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 55.06 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 53.76 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.59 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| tibialis anterior | UBERON:0001385 | 51.71 | silver quality |
| ileal mucosa | UBERON:0000331 | 51.26 | silver quality |
| pancreatic ductal cell | CL:0002079 | 51.23 | silver quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| deltoid | UBERON:0001476 | 50.12 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.59 | gold quality |
| fallopian tube | UBERON:0003889 | 46.03 | gold quality |
| prefrontal cortex | UBERON:0000451 | 45.61 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| upper leg skin | UBERON:0004262 | 45.25 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting PRSS54, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-3913-3P | 99.74 | 66.53 | 938 |
| HSA-MIR-7157-5P | 99.66 | 69.33 | 1829 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
| HSA-MIR-338-3P | 98.14 | 67.38 | 1137 |
| HSA-MIR-4797-3P | 97.48 | 67.14 | 989 |
| HSA-MIR-5000-5P | 97.40 | 66.11 | 1055 |
| HSA-MIR-514A-3P | 96.43 | 67.77 | 1048 |
| HSA-MIR-514B-3P | 96.43 | 67.77 | 1048 |
| HSA-MIR-6858-3P | 96.37 | 64.41 | 771 |
| HSA-MIR-4264 | 96.35 | 64.76 | 1480 |
Literature-anchored findings (GeneRIF, showing 1)
- Testis-specific serine protease PRSS54 regulates acrosomal granule localization and sperm head morphogenesis in micedagger. (PMID:35863763)
Cross-species orthologs
13 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prss54 | ENSMUSG00000048400 |
| rattus_norvegicus | Prss54 | ENSRNOG00000023092 |
| drosophila_melanogaster | CG9673 | FBGN0030775 |
| drosophila_melanogaster | CG4477 | FBGN0035971 |
| drosophila_melanogaster | CG17404 | FBGN0038001 |
| drosophila_melanogaster | CG12256 | FBGN0038002 |
| drosophila_melanogaster | CG3916 | FBGN0038003 |
| drosophila_melanogaster | CG17477 | FBGN0038479 |
| drosophila_melanogaster | CG4053 | FBGN0038482 |
| drosophila_melanogaster | CG31269 | FBGN0051269 |
| drosophila_melanogaster | CG32808 | FBGN0052808 |
| drosophila_melanogaster | Phae2 | FBGN0263235 |
| drosophila_melanogaster | Send2 | FBGN0264253 |
Paralogs (12): KLK14 (ENSG00000129437), KLK8 (ENSG00000129455), TMPRSS4 (ENSG00000137648), KLK3 (ENSG00000142515), KLK1 (ENSG00000167748), KLK4 (ENSG00000167749), KLK2 (ENSG00000167751), KLK5 (ENSG00000167754), KLK11 (ENSG00000167757), KLK7 (ENSG00000169035), KLK12 (ENSG00000186474), PRSS58 (ENSG00000258223)
Protein
Protein identifiers
Inactive serine protease 54 — Q6PEW0 (reviewed: Q6PEW0)
Alternative names: Cancer/testis antigen 67, Plasma kallikrein-like protein 4
All UniProt accessions (5): Q6PEW0, A0A140VKC3, F5H6C6, H3BNY0, H3BQS7
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the peptidase S1 family. Plasma kallikrein subfamily.
RefSeq proteins (3): NP_001073961, NP_001292102, NP_001292103 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001254 | Trypsin_dom | Domain |
| IPR009003 | Peptidase_S1_PA | Homologous_superfamily |
| IPR043504 |
Pfam: PF00089
UniProt features (13 total): sequence variant 3, disulfide bond 3, glycosylation site 2, signal peptide 1, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6PEW0-F1 | 67.53 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 164–227, 195–205, 217–248
Glycosylation sites (2): 123, 327
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
chr16q21, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP, MIR4310, MIR6858_3P, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP, GOMF_SERINE_HYDROLASE_ACTIVITY, GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP, GSE7460_TREG_VS_TCONV_ACT_DN, GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP, GOMF_ENDOPEPTIDASE_ACTIVITY, GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN
GO Biological Process (1): proteolysis (GO:0006508)
GO Molecular Function (1): serine-type endopeptidase activity (GO:0004252)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
340 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRSS54 | PRSS37 | A4D1T9 | 643 |
| PRSS54 | TEX55 | Q96M34 | 643 |
| PRSS54 | OR5C1 | Q8NGR4 | 598 |
| PRSS54 | SPMAP2 | Q9P2T0 | 571 |
| PRSS54 | CT62 | P0C5K7 | 541 |
| PRSS54 | SPATA46 | Q5T0L3 | 507 |
| PRSS54 | C1orf167 | Q5SNV9 | 479 |
| PRSS54 | CPXCR1 | Q8N123 | 479 |
| PRSS54 | SPMIP9 | Q96LM6 | 479 |
| PRSS54 | OR4X1 | Q8NH49 | 452 |
| PRSS54 | PASD1 | Q8IV76 | 447 |
| PRSS54 | RBM46 | Q8TBY0 | 418 |
| PRSS54 | GPR25 | O00155 | 414 |
| PRSS54 | OR7C2 | O60412 | 400 |
| PRSS54 | ADAM29 | Q9UKF5 | 397 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GVH4, A1L453, A4D1T9, A6H6T1, A8MTI9, A8QL53, A8QL57, B5U6Y3, E5RG02, O35453, O70169, P00745, P04070, P08709, P0CG03, P0DJE9, P22891, Q14BX2, Q28278, Q28661, Q2F9P2, Q2F9P4, Q2TV78, Q3V0Q7, Q402U7, Q4R7Y7, Q5FBW1, Q5M8S2, Q6AXZ6, Q6AY28, Q6IE62, Q6IE63, Q6PEW0, Q6UWB4, Q76HL1, Q7M756, Q7M761, Q7RTY5, Q7RTY7, Q7Z5A4
Diamond homologs: Q6AY28, Q6PEW0, Q6UWB4, Q7M756, Q2KJ63, E5AJX2, P03951, P03952, Q5NTB3, Q91Y47
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1247 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:58284728:CA:C | acceptor_gain | 1.0000 |
| 16:58284729:A:AC | acceptor_gain | 1.0000 |
| 16:58284729:A:C | acceptor_gain | 1.0000 |
| 16:58285935:A:C | donor_gain | 1.0000 |
| 16:58293626:C:A | donor_gain | 1.0000 |
| 16:58280754:CCCC:C | acceptor_gain | 0.9900 |
| 16:58280755:CCC:C | acceptor_gain | 0.9900 |
| 16:58280755:CCCC:C | acceptor_gain | 0.9900 |
| 16:58280756:CC:C | acceptor_gain | 0.9900 |
| 16:58280756:CCC:C | acceptor_gain | 0.9900 |
| 16:58280756:CCCTG:C | acceptor_loss | 0.9900 |
| 16:58280757:CC:C | acceptor_gain | 0.9900 |
| 16:58280758:C:CC | acceptor_gain | 0.9900 |
| 16:58280759:T:C | acceptor_loss | 0.9900 |
| 16:58284566:G:C | donor_gain | 0.9900 |
| 16:58284727:CCA:C | acceptor_gain | 0.9900 |
| 16:58285955:T:TA | donor_gain | 0.9900 |
| 16:58293730:A:AC | donor_gain | 0.9900 |
| 16:58293731:C:CC | donor_gain | 0.9900 |
| 16:58280753:TCCCC:T | acceptor_gain | 0.9800 |
| 16:58280754:CCCCC:C | acceptor_gain | 0.9800 |
| 16:58284718:CTGT:C | acceptor_gain | 0.9800 |
| 16:58284729:A:T | acceptor_gain | 0.9800 |
| 16:58294798:CAGAG:C | donor_gain | 0.9800 |
| 16:58294799:A:AC | donor_gain | 0.9800 |
| 16:58294799:AGAGA:A | donor_gain | 0.9800 |
| 16:58294800:G:C | donor_gain | 0.9800 |
| 16:58294898:CATG:C | donor_gain | 0.9800 |
| 16:58294899:ATGA:A | donor_gain | 0.9800 |
| 16:58280760:G:GC | acceptor_gain | 0.9700 |
AlphaMissense
2612 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:58290982:G:C | S80R | 0.997 |
| 16:58290982:G:T | S80R | 0.997 |
| 16:58290984:T:G | S80R | 0.997 |
| 16:58285952:C:A | W169C | 0.996 |
| 16:58285952:C:G | W169C | 0.996 |
| 16:58280623:C:A | W263C | 0.994 |
| 16:58280623:C:G | W263C | 0.994 |
| 16:58286068:C:G | A131P | 0.993 |
| 16:58285954:A:G | W169R | 0.992 |
| 16:58285954:A:T | W169R | 0.992 |
| 16:58291050:A:G | S58P | 0.992 |
| 16:58286061:A:G | L133P | 0.991 |
| 16:58286096:A:C | F121L | 0.991 |
| 16:58286096:A:T | F121L | 0.991 |
| 16:58286098:A:G | F121L | 0.991 |
| 16:58286067:G:T | A131D | 0.990 |
| 16:58280625:A:G | W263R | 0.989 |
| 16:58280625:A:T | W263R | 0.989 |
| 16:58286064:A:G | L132P | 0.989 |
| 16:58280732:C:G | C227S | 0.988 |
| 16:58280733:A:T | C227S | 0.988 |
| 16:58286072:G:C | N129K | 0.987 |
| 16:58286072:G:T | N129K | 0.987 |
| 16:58291059:A:G | W55R | 0.987 |
| 16:58291059:A:T | W55R | 0.987 |
| 16:58285967:G:C | C164W | 0.985 |
| 16:58291013:C:T | G70D | 0.985 |
| 16:58291043:T:G | Q60P | 0.985 |
| 16:58280733:A:G | C227R | 0.983 |
| 16:58285968:C:G | C164S | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000003641 (16:58280355 G>A), RS1000032484 (16:58295691 C>T), RS1000075756 (16:58280128 G>A,T), RS1000156624 (16:58290058 T>A), RS1000294649 (16:58293043 A>G,T), RS1000451091 (16:58286932 A>G), RS1000829508 (16:58287173 T>A), RS1001054161 (16:58281865 C>G), RS1001190895 (16:58294403 T>G), RS1001321074 (16:58286468 T>C), RS1001422959 (16:58293747 G>A), RS1002056437 (16:58283439 A>G), RS1002209588 (16:58295337 A>G), RS1002314647 (16:58289319 G>A), RS1002459544 (16:58289581 T>TTC)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003121_9 | Alcohol dependence | 5.000000e-06 |
| GCST003155_34 | Systemic lupus erythematosus | 4.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | affects phosphorylation | 1 |
| bisphenol A | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alcohol dependence